Cargando…

Autocrine TNF-α Increases Penetration of Myelin-Associated Glycoprotein Antibodies Across the Blood-Nerve Barrier in Anti-MAG Neuropathy

BACKGROUND AND OBJECTIVES: Deposition of myelin-associated glycoprotein (MAG) immunoglobulin M (IgM) antibodies in the sural nerve is a key feature in anti-MAG neuropathy. Whether the blood-nerve barrier (BNB) is disrupted in anti-MAG neuropathy remains elusive.We aimed to evaluate the effect of ser...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Ryota, Shimizu, Fumitaka, Kuwahara, Motoi, Mizukami, Yoichi, Watanabe, Kenji, Maeda, Toshihiko, Sano, Yasuteru, Takeshita, Yukio, Koga, Michiaki, Kusunoki, Susumu, Kanda, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944621/
https://www.ncbi.nlm.nih.gov/pubmed/36810162
http://dx.doi.org/10.1212/NXI.0000000000200086
_version_ 1784891954408980480
author Sato, Ryota
Shimizu, Fumitaka
Kuwahara, Motoi
Mizukami, Yoichi
Watanabe, Kenji
Maeda, Toshihiko
Sano, Yasuteru
Takeshita, Yukio
Koga, Michiaki
Kusunoki, Susumu
Kanda, Takashi
author_facet Sato, Ryota
Shimizu, Fumitaka
Kuwahara, Motoi
Mizukami, Yoichi
Watanabe, Kenji
Maeda, Toshihiko
Sano, Yasuteru
Takeshita, Yukio
Koga, Michiaki
Kusunoki, Susumu
Kanda, Takashi
author_sort Sato, Ryota
collection PubMed
description BACKGROUND AND OBJECTIVES: Deposition of myelin-associated glycoprotein (MAG) immunoglobulin M (IgM) antibodies in the sural nerve is a key feature in anti-MAG neuropathy. Whether the blood-nerve barrier (BNB) is disrupted in anti-MAG neuropathy remains elusive.We aimed to evaluate the effect of sera from anti-MAG neuropathy at the molecular level using our in vitro human BNB model and observe the change of BNB endothelial cells in the sural nerve of anti-MAG neuropathy. METHODS: Diluted sera from patients with anti-MAG neuropathy (n = 16), monoclonal gammopathies of undetermined significance (MGUS) neuropathy (n = 7), amyotrophic lateral sclerosis (ALS, n = 10), and healthy controls (HCs, n = 10) incubated with human BNB endothelial cells to identify the key molecule of BNB activation using RNA-seq and a high-content imaging system, and exposed with a BNB coculture model to evaluate small molecule/IgG/IgM/anti-MAG antibody permeability. RESULTS: RNA-seq and the high-content imaging system showed the significant upregulation of tumor necrosis factor (TNF-α) and nuclear factor-kappa B (NF-κB) in BNB endothelial cells after exposure to sera from patients with anti-MAG neuropathy, whereas the serum TNF-α concentration was not changed among the MAG/MGUS/ALS/HC groups. Sera from patients with anti-MAG neuropathy did not increase 10-kDa dextran or IgG permeability but enhanced IgM and anti-MAG antibody permeability. Sural nerve biopsy specimens from patients with anti-MAG neuropathy showed higher TNF-α expression levels in BNB endothelial cells and preservation of the structural integrity of the tight junctions and the presence of more vesicles in BNB endothelial cells. Neutralization of TNF-α reduces IgM/anti-MAG antibody permeability. DISCUSSION: Sera from individuals with anti-MAG neuropathy increased transcellular IgM/anti-MAG antibody permeability via autocrine TNF-α secretion and NF-κB signaling in the BNB.
format Online
Article
Text
id pubmed-9944621
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-99446212023-02-23 Autocrine TNF-α Increases Penetration of Myelin-Associated Glycoprotein Antibodies Across the Blood-Nerve Barrier in Anti-MAG Neuropathy Sato, Ryota Shimizu, Fumitaka Kuwahara, Motoi Mizukami, Yoichi Watanabe, Kenji Maeda, Toshihiko Sano, Yasuteru Takeshita, Yukio Koga, Michiaki Kusunoki, Susumu Kanda, Takashi Neurol Neuroimmunol Neuroinflamm Research Article BACKGROUND AND OBJECTIVES: Deposition of myelin-associated glycoprotein (MAG) immunoglobulin M (IgM) antibodies in the sural nerve is a key feature in anti-MAG neuropathy. Whether the blood-nerve barrier (BNB) is disrupted in anti-MAG neuropathy remains elusive.We aimed to evaluate the effect of sera from anti-MAG neuropathy at the molecular level using our in vitro human BNB model and observe the change of BNB endothelial cells in the sural nerve of anti-MAG neuropathy. METHODS: Diluted sera from patients with anti-MAG neuropathy (n = 16), monoclonal gammopathies of undetermined significance (MGUS) neuropathy (n = 7), amyotrophic lateral sclerosis (ALS, n = 10), and healthy controls (HCs, n = 10) incubated with human BNB endothelial cells to identify the key molecule of BNB activation using RNA-seq and a high-content imaging system, and exposed with a BNB coculture model to evaluate small molecule/IgG/IgM/anti-MAG antibody permeability. RESULTS: RNA-seq and the high-content imaging system showed the significant upregulation of tumor necrosis factor (TNF-α) and nuclear factor-kappa B (NF-κB) in BNB endothelial cells after exposure to sera from patients with anti-MAG neuropathy, whereas the serum TNF-α concentration was not changed among the MAG/MGUS/ALS/HC groups. Sera from patients with anti-MAG neuropathy did not increase 10-kDa dextran or IgG permeability but enhanced IgM and anti-MAG antibody permeability. Sural nerve biopsy specimens from patients with anti-MAG neuropathy showed higher TNF-α expression levels in BNB endothelial cells and preservation of the structural integrity of the tight junctions and the presence of more vesicles in BNB endothelial cells. Neutralization of TNF-α reduces IgM/anti-MAG antibody permeability. DISCUSSION: Sera from individuals with anti-MAG neuropathy increased transcellular IgM/anti-MAG antibody permeability via autocrine TNF-α secretion and NF-κB signaling in the BNB. Lippincott Williams & Wilkins 2023-02-21 /pmc/articles/PMC9944621/ /pubmed/36810162 http://dx.doi.org/10.1212/NXI.0000000000200086 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Research Article
Sato, Ryota
Shimizu, Fumitaka
Kuwahara, Motoi
Mizukami, Yoichi
Watanabe, Kenji
Maeda, Toshihiko
Sano, Yasuteru
Takeshita, Yukio
Koga, Michiaki
Kusunoki, Susumu
Kanda, Takashi
Autocrine TNF-α Increases Penetration of Myelin-Associated Glycoprotein Antibodies Across the Blood-Nerve Barrier in Anti-MAG Neuropathy
title Autocrine TNF-α Increases Penetration of Myelin-Associated Glycoprotein Antibodies Across the Blood-Nerve Barrier in Anti-MAG Neuropathy
title_full Autocrine TNF-α Increases Penetration of Myelin-Associated Glycoprotein Antibodies Across the Blood-Nerve Barrier in Anti-MAG Neuropathy
title_fullStr Autocrine TNF-α Increases Penetration of Myelin-Associated Glycoprotein Antibodies Across the Blood-Nerve Barrier in Anti-MAG Neuropathy
title_full_unstemmed Autocrine TNF-α Increases Penetration of Myelin-Associated Glycoprotein Antibodies Across the Blood-Nerve Barrier in Anti-MAG Neuropathy
title_short Autocrine TNF-α Increases Penetration of Myelin-Associated Glycoprotein Antibodies Across the Blood-Nerve Barrier in Anti-MAG Neuropathy
title_sort autocrine tnf-α increases penetration of myelin-associated glycoprotein antibodies across the blood-nerve barrier in anti-mag neuropathy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944621/
https://www.ncbi.nlm.nih.gov/pubmed/36810162
http://dx.doi.org/10.1212/NXI.0000000000200086
work_keys_str_mv AT satoryota autocrinetnfaincreasespenetrationofmyelinassociatedglycoproteinantibodiesacrossthebloodnervebarrierinantimagneuropathy
AT shimizufumitaka autocrinetnfaincreasespenetrationofmyelinassociatedglycoproteinantibodiesacrossthebloodnervebarrierinantimagneuropathy
AT kuwaharamotoi autocrinetnfaincreasespenetrationofmyelinassociatedglycoproteinantibodiesacrossthebloodnervebarrierinantimagneuropathy
AT mizukamiyoichi autocrinetnfaincreasespenetrationofmyelinassociatedglycoproteinantibodiesacrossthebloodnervebarrierinantimagneuropathy
AT watanabekenji autocrinetnfaincreasespenetrationofmyelinassociatedglycoproteinantibodiesacrossthebloodnervebarrierinantimagneuropathy
AT maedatoshihiko autocrinetnfaincreasespenetrationofmyelinassociatedglycoproteinantibodiesacrossthebloodnervebarrierinantimagneuropathy
AT sanoyasuteru autocrinetnfaincreasespenetrationofmyelinassociatedglycoproteinantibodiesacrossthebloodnervebarrierinantimagneuropathy
AT takeshitayukio autocrinetnfaincreasespenetrationofmyelinassociatedglycoproteinantibodiesacrossthebloodnervebarrierinantimagneuropathy
AT kogamichiaki autocrinetnfaincreasespenetrationofmyelinassociatedglycoproteinantibodiesacrossthebloodnervebarrierinantimagneuropathy
AT kusunokisusumu autocrinetnfaincreasespenetrationofmyelinassociatedglycoproteinantibodiesacrossthebloodnervebarrierinantimagneuropathy
AT kandatakashi autocrinetnfaincreasespenetrationofmyelinassociatedglycoproteinantibodiesacrossthebloodnervebarrierinantimagneuropathy